Session 16 - 12th CROI

Home

Session 16 Symposium
Chemokine Receptor Blockade: Bench to Bedside
Wednesday, 4 - 6 pm
Ballroom B/C

Conveners:

  Barbara Weiser
  Wadsworth Ctr, Albany, NY, USA

  Cecilia Cheng-Mayer
  Aaron Diamond AIDS Res Ctr, Rockefeller Univ, New York, NY, USA

4:00 pm 56	Preclinical Development of Chemokine Receptor Inhibitors Donald E Mosier The Scripps Res Inst, La Jolla, CA, USA
4:30 pm 57	Clinical Activity and Efficacy Trials of Chemokine Receptor Inhibitors Daniel Kuritzkes Brigham and Women's Hosp, Harvard Med Sch, Boston, MA, USA
5:00 pm 58	Clinical Pharmacokinetics and Pharmacodynamics of Chemokine Inhibitors: Implications for Rational Dosing Craig W Hendrix Bloomberg Sch of Publ Hlth, John Hopkins Univ, Baltimore, MD, USA
5:30 pm 59	Resistance to HIV Chemokine Receptor Antagonists Christos J Petropoulos*¹, W Huang¹, J Toma¹, S Fransen¹, S Bonhoeffer², and J Whitcomb¹ ¹ViroLogic, Inc, South San Francisco, CA, USA and ²ETH Zurich, Switzerland